3-Hydroxyacetaminophen - CAS 37519-14-5
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
3-Hydroxyacetaminophen
Catalog Number:
37519-14-5
Synonyms:
Acetaminophen metabolite 3-hydroxy-acetaminophen; N-(3,4-dihydroxyphenyl)acetamide;
CAS Number:
37519-14-5
Description:
A metabolite of acetaminophen, which is is a pain reliever and a fever reducer.
Molecular Weight:
167.16
Molecular Formula:
C8H9NO3
Quantity:
Milligrams-Grams
Quality Standard:
Enterprise Standard
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
CC(=O)NC1=CC(=C(C=C1)O)O
InChI:
1S/C8H9NO3/c1-5(10)9-6-2-3-7(11)8(12)4-6/h2-4,11-12H,1H3,(H,9,10)
InChIKey:
IPFBMHOMTSBTSU-UHFFFAOYSA-N
Targets:
Others
Chemical Structure
CAS 37519-14-5 3-Hydroxyacetaminophen

Related Products


CAS 155294-62-5 NB-598 Maleate

NB-598 Maleate
(CAS: 155294-62-5)

SE inhibitor NB-598 significantly inhibited both basal and glucose-stimulated insulin secretion from mouse pancreatic islets. CaV channels were markedly inhibit...

CAS 102791-47-9 Nanterinone

Nanterinone
(CAS: 102791-47-9)

Nanterinone is a novel positive inotropic and balanced-type vasodilating drug partially based on phosphodiesterase III inhibition. It exhibits acute hemodynamic...

CAS 3615-24-5 Ramifenazone

Ramifenazone
(CAS: 3615-24-5)

Ramifenazone is a non-steroidal anti-inflammatory synthetic reagent.

CAS 10389-72-7 Clortermine hydrochloride

Clortermine hydrochloride
(CAS: 10389-72-7)

Clortermine hydrochloride is a new non-amphetamine anorexigenic agent. It is used as an anti-obesity drug.

HI TOPK 032
(CAS: 487020-03-1)

HI TOPK 032 is a novel TOPK inhibitor as a T-LAK-cell-originated protein kinase (TOPK) inhibitor, blocking phosphorylation of the substrate histone H2AX with a...

CAS 26328-04-1 Cinepazide maleate

Cinepazide maleate
(CAS: 26328-04-1)

Cinepazide maleate is a maleate salt form of cinepazide which is a vasodilator.

Evogliptin hydrochloride
(CAS: 1246960-27-9)

CAS 2076-91-7 TPT-260 2HCl

TPT-260 2HCl
(CAS: 2076-91-7)

TPT-260 is a thiophene thiourea derivative with molecule weight 260.00 in free base form. There is no formal name yet, we temporally call this molecule as TPT-2...

CAS 441785-25-7 Besifovir

Besifovir
(CAS: 441785-25-7)

Besifovir is an orally available phosphonate nucleotide for the potential treatment of hepatitis B virus infection was well tolerated and also had a good clinic...

CAS 484-20-8 Bergapten

Bergapten
(CAS: 484-20-8)

Bergapten is a psoralen that can be photoactivated and is capable of crossing-linking DNA, covalently modifying proteins and lipids, and consequently inhibiting...

CAS 915363-56-3 Cot inhibitor-2

Cot inhibitor-2
(CAS: 915363-56-3)

Cot inhibitor-2 is a COT/Tpl2 inhibitor.

CAS 3621-36-1 Columbamine

Columbamine
(CAS: 3621-36-1)

Extract from the roots of Coptis chinensis Franch, shows strong activity with IC50 48.1 µM.

CAS 36062-07-4 Octahydrocurcumin

Octahydrocurcumin
(CAS: 36062-07-4)

OKT3-induced PBMC proliferation was inhibited by octahydrocurcumin with IC50 of 82 uM. The investigated substances with the strongest effect on radical scavengi...

CAS 109229-57-4 Englitazone sodium

Englitazone sodium
(CAS: 109229-57-4)

Englitazone sodium is a novel blocker of NSCa and KATP channels. It is an antidiabetic agent.

BMS 182264
(CAS: 127749-54-6)

BMS 182264 is a bio-active chemical, but few detailed information has been published yet.

CAS 97759-16-5 S186

S186
(CAS: 97759-16-5)

S186 is a kind of sodium salts of calcium-acetylpropylamine phosphonate(APA). It is a new strontium-specific chelating agent. It has also been approved by Shang...

Emixustat hydrochloride
(CAS: 1141934-97-5)

The hydrochloride salt form of Emixustat which could effectively inhibit the production of 11-cis-retinol which is related to age-related macular degeneration.

CAS 179599-82-7 Lotrafiban hydrochloride

Lotrafiban hydrochloride
(CAS: 179599-82-7)

The hydrochloride salt form of Lotrafiban, a benzodiazepine derivative, has been found to be a platelet glycoprotein IIb/IIIa blocker and was once studied in ca...

CAS 143982-31-4 LY 186564

LY 186564
(CAS: 143982-31-4)

LY 186564 is a bio-active chemical,but no detailed information has been published yet.

CAS 141206-42-0 N-(n-Butyl)deoxygalactonojirimycin

N-(n-Butyl)deoxygalactonojirimycin
(CAS: 141206-42-0)

Lucerastat is a selective α-D-galactosidase inhibitor. It can prevent glucosylceramide biosynthesis both in vitro and in mouse models of lysosome storage disord...

Reference Reading


1.Role of CYP2A5 and 2G1 in acetaminophen metabolism and toxicity in the olfactory mucosa of the Cyp1a2(-/-) mouse.
Genter MB1, Liang HC, Gu J, Ding X, Negishi M, McKinnon RA, Nebert DW. Biochem Pharmacol. 1998 Jun 1;55(11):1819-26.
Acetaminophen (AP) is a widely-used analgesic agent that has been linked to human liver and kidney disease with prolonged or high-dose usage. In rodents, the target organs that are affected include liver, kidney, and the olfactory mucosa. AP toxicity requires cytochrome P450(CYP)-mediated metabolic activation, and the isozymes CYP1A2, 2E1, and 3A are known to activate AP in the human. In the present study, we determined that olfactory mucosal toxicity of AP was not different between the Cyp1a2(+/+) wild-type and the Cyp1a2(-/-) knockout mouse, whereas the hepatic toxicity of AP was significantly diminished in Cyp1a2(-/-) mice. Western blots of olfactory mucosa revealed that CYP2E1 and CYP3A levels are similar between untreated Cyp1a2(+/+) and Cyp1a2(-/-) mice. Diallyl sulfide (DAS), a known inhibitor of CYP2E1 and of CYP2A10/2A11 (the rabbit orthologue of mouse CYP2A5), completely eliminated olfactory toxicity of AP in both the Cyp1a2(-/-) and wild-type mouse olfactory mucosa.
2.Dysmorphogenesis elicited by microinjected acetaminophen analogs and metabolites in rat embryos cultured in vitro.
Stark KL1, Lee QP, Namkung MJ, Harris C, Juchau MR. J Pharmacol Exp Ther. 1990 Oct;255(1):74-82.
Direct additions of acetaminophen (APAP), 3,5-dimethylacetaminophen, 3-hydroxyacetaminophen or 3-methoxyacetaminophen to the medium of cultured embryos each produced an increased incidence of morphologically similar, abnormally open anterior neuropores. Approximate concentrations required to produce an equal incidence were 0.5 mM, 1.0 mM, 0.1 mM and 0.75 mM, respectively. In contrast, 2.6-dimethylacetaminophen and N-acetyl-p-benzoquinoneimine failed to produce elevated incidences of abnormal neurulation unaccompanied by marked growth retardation. However, with intra-amniotic microinjections, 3-hydroxyacetaminophen and N-acetyl-p-benzoquinoneimine were roughly equipotent for eliciting abnormal neurulation, whereas 3-methoxyacetaminophen required greater than 30-fold higher concentrations. This suggests that N-acetyl-p-benzoquinoneimine does not readily transit the visceral yolk sac and would likely not be a major factor in APAP-elicited neural tube abnormalities unless generated in target tissues.
3.Selective vasodilator and chronotropic actions of 3',4'-dihydroxyflavonol in conscious sheep.
Wang S1, Dusting GJ, Woodman OL, May CN. Eur J Pharmacol. 2004 Apr 26;491(1):43-51.
Flavonoids are known to relax isolated large arteries, but the cardiovascular actions of flavonoids are not well studied in vivo. Hence, we determined the systemic and regional haemodynamic responses to a novel synthetic flavonol, 3',4'-dihydroxyflavonol (DiOHF), in conscious sheep previously instrumented with flow probes on the aorta and coronary, mesenteric, renal, and iliac arteries. Intravenous injection of DiOHF (1.0 mg/kg) caused a delayed but prolonged vasodilatation in the coronary and renal vascular beds, with no changes in the mesenteric or iliac vascular beds. DiOHF induced prolonged increases in heart rate and cardiac output without altering arterial pressure. Pretreatment with Nomega-nitro-L-arginine, a nonspecific inhibitor of nitric oxide synthase, abolished all the cardiovascular effects of DiOHF. The results indicate that DiOHF caused a nitric oxide-dependent vasodilatation of the coronary and renal vasculature and an increase in cardiac output due to its chronotropic action.
4.Enzymatic synthesis of 3'-hydroxyacetaminophen catalyzed by tyrosinase.
Valero E1, Lozano MI, Varón R, García-Carmona F. Biotechnol Prog. 2003 Nov-Dec;19(6):1632-8.
3'-Hydroxyacetaminophen, a catechol metabolite of N-acetyl-p-aminophenol (acetaminophen) and N-acetyl-m-aminophenol (a structural analogue of acetaminophen and considered as a possible alternative because it is not hepatotoxic), is enzymatically synthesized for the first time using mushroom tyrosinase. Although reported to be weakly hepatotoxic in vivo, this catechol derivative of acetaminophen is not commercially available. This compound was obtained from its monophenolic precursor, acetaminophen, using the enzyme tyrosinase in the presence of an excess of ascorbic acid, thus reducing back the o-quinone product of catalytic activity to the catechol acetaminophen derivative. A mathematical model of the system is proposed, which is also applicable to the tyrosinase-mediated synthesis of any o-diphenolic compound from its corresponding monophenol. This synthesis procedure is continuous, easy to perform and control, and adaptable to a bioreactor with the immobilized enzyme for industrial purposes in a nonpolluting way.